查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1748824

神經血栓切除設備市場－全球產業規模、佔有率、趨勢、機會與預測、按產品、按最終用戶、按地區和競爭情況細分，2020-2030 年

Neurothrombectomy Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By End User, By Region, & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球神經血栓切除設備市場價值為 7.394 億美元，預計到 2030 年將達到 11.0597 億美元，預測期內的複合年成長率為 6.90%。這一成長主要得益於全球缺血性卒中患病率的上升以及對先進機械血栓切除干涉措施的需求不斷成長。神經血栓切除設備（例如支架取栓器、抽吸導管和血管圈套器）對於清除大血管閉塞 (LVO) 患者的血栓至關重要，可顯著改善急性缺血性中風病例的預後。技術創新和診斷影像的改進使得能夠更早、更準確地識別符合條件的患者，從而支持更廣泛地採用這些挽救生命的干涉措施。儘管挑戰依然存在，尤其是在資源匱乏的地區，專科醫生的可用性和手術的可及性方面，但預計對卒中治療基礎設施的投資不斷增加以及設備功能的持續進步將維持全球市場擴張。

市場概覽
預測期 2026-2030
2024年市場規模 7.394億美元
2030年市場規模 11.0597億美元
2025-2030 年複合年成長率 6.90%
成長最快的領域 血塊回收器
最大的市場 北美洲

關鍵市場促進因素

全球缺血性中風和大血管閉塞發生率上升

主要市場挑戰

熟練的神經介入專家短缺

主要市場趨勢

新興市場中風護理基礎設施的擴展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：神經血栓切除設備市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（血塊取出器、抽吸裝置、血管圈套器）
    • 按最終用戶（醫院、急診、門診手術中心）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美神經血栓切除設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲神經血栓切除設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太神經血栓切除設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲神經血栓切除術設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲神經血栓切除術設備市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球神經血栓切除術設備市場：SWOT 分析

第 14 章：競爭格局

  • Medtronic Plc.
  • Stryker Corporation
  • Acandis GmbH
  • Phenox GmbH
  • Penumbra Inc.
  • Vesalio

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 7590

The Global Neurothrombectomy Devices Market was valued at USD 739.40 Million in 2024 and is projected to reach USD 1105.97 Million by 2030, growing at a CAGR of 6.90% during the forecast period. This growth is primarily fueled by the rising global prevalence of ischemic strokes and the increasing need for advanced mechanical thrombectomy interventions. Neurothrombectomy devices-such as stent retrievers, aspiration catheters, and vascular snares-are central to removing clots in patients with large vessel occlusions (LVOs), significantly improving outcomes in acute ischemic stroke cases. Technological innovation and improved diagnostic imaging are enabling earlier and more accurate identification of eligible patients, supporting broader adoption of these life-saving interventions. Although challenges remain, particularly around specialist availability and procedural access in low-resource settings, growing investment in stroke treatment infrastructure and ongoing advancements in device capabilities are expected to sustain market expansion globally.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 739.40 Million
Market Size 2030USD 1105.97 Million
CAGR 2025-20306.90%
Fastest Growing SegmentClot Retriever
Largest MarketNorth America

Key Market Drivers

Rising Global Incidence of Ischemic Stroke and Large Vessel Occlusions

Ischemic stroke continues to be a leading cause of death and long-term disability worldwide, accounting for approximately 85% of all stroke events. A large subset of these are large vessel occlusions (LVOs), which require urgent intervention to restore cerebral perfusion. More than 12 million strokes occur globally each year, with a substantial portion reported in low- and middle-income regions. This increase is linked to risk factors such as aging populations, sedentary habits, and rising incidences of hypertension, diabetes, and obesity.

LVOs, in particular, necessitate mechanical thrombectomy procedures as they are often unresponsive to intravenous thrombolytic therapy. The use of advanced imaging techniques like CT angiography has enhanced the ability of clinicians to detect LVOs early, increasing the number of patients eligible for intervention. As a result, the clinical demand for neurothrombectomy devices continues to grow, particularly in stroke-ready hospitals and neurointervention centers worldwide.

Key Market Challenges

Shortage of Skilled Neurointerventional Specialists

The expansion of the neurothrombectomy devices market is constrained by a shortage of trained neurointerventional professionals. Mechanical thrombectomy is a technically demanding procedure that requires real-time imaging, expert handling of advanced devices, and multidisciplinary support. Many countries-especially in parts of Asia, Africa, and Latin America-lack adequate training programs and medical infrastructure to perform these procedures at scale.

Even in well-developed healthcare systems, the demand for thrombectomy can exceed available resources, resulting in treatment delays. The scarcity of qualified specialists not only limits procedural accessibility but also reduces patient throughput and clinical outcomes, posing a significant barrier to full market potential.

Key Market Trends

Expansion of Stroke Care Infrastructure in Emerging Markets

To address the growing burden of stroke, many emerging economies are prioritizing investment in dedicated stroke care facilities and interventional capabilities. Healthcare systems across Asia-Pacific, Latin America, and the Middle East are establishing new stroke centers, rolling out mobile stroke units, and training local specialists in neurointerventional techniques.

International organizations and private healthcare providers are also investing in tele-stroke services, enabling remote diagnosis and timely transfer of patients to thrombectomy-equipped hospitals. These efforts are improving procedural access in previously underserved areas and are expected to increase demand for devices such as stent retrievers and aspiration systems. As stroke care systems become more robust and widespread, market opportunities are expanding well beyond traditional strongholds in North America and Europe.

Key Market Players

  • Medtronic Plc.
  • Stryker Corporation
  • Acandis GmbH
  • Phenox GmbH
  • Penumbra Inc.
  • Vesalio

Report Scope:

In this report, the Global Neurothrombectomy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurothrombectomy Devices Market, By Product:

  • Clot Retrievers
  • Aspiration/ Suction Devices
  • Vascular Snares

Neurothrombectomy Devices Market, By End User:

  • Hospital
  • Emergency Clinics
  • Ambulatory Surgical Centers

Neurothrombectomy Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurothrombectomy Devices Market.

Available Customizations:

Global Neurothrombectomy Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Neurothrombectomy Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Clot Retrievers, Aspiration/ Suction Devices, Vascular Snares)
    • 5.2.2. By End User (Hospital, Emergency Clinics, Ambulatory Surgical Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Neurothrombectomy Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Neurothrombectomy Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Neurothrombectomy Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Neurothrombectomy Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End User

7. Europe Neurothrombectomy Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Neurothrombectomy Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End User
    • 7.3.2. United Kingdom Neurothrombectomy Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End User
    • 7.3.3. Italy Neurothrombectomy Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End User
    • 7.3.4. France Neurothrombectomy Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Neurothrombectomy Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End User

8. Asia-Pacific Neurothrombectomy Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Neurothrombectomy Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End User
    • 8.3.2. India Neurothrombectomy Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Neurothrombectomy Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Neurothrombectomy Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Neurothrombectomy Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End User

9. South America Neurothrombectomy Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Neurothrombectomy Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Neurothrombectomy Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Neurothrombectomy Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End User

10. Middle East and Africa Neurothrombectomy Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Neurothrombectomy Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Neurothrombectomy Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Neurothrombectomy Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Neurothrombectomy Devices Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Medtronic Plc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Stryker Corporation
  • 14.3. Acandis GmbH
  • 14.4. Phenox GmbH
  • 14.5. Penumbra Inc.
  • 14.6. Vesalio

15. Strategic Recommendations

16. About Us & Disclaimer